Another work reported the use of a nanoparticle-complex based on different FLT3 inhibitors, namely Midostaurin, Sorafenib, Lestaurtinib, and Quizartinib, which were independently loaded onto gelatin-coated gold nanoparticles with promising results against THP1 acute myeloid leukemia cells [39]. Here, FLT3 is linked to acute myeloid leukemia.